Results 21 to 30 of about 28,806 (223)

The reform of the Italian legislation on childhood immunization [PDF]

open access: yes, 2018
Upon the proposal of the Italian government, Law n. 191/2017 has been enacted, meant to considerably raise the number of mandatory vaccinations, while leaving several others merely "recommended" (non-mandatory).
Cocchiara, Rosario Andrea   +4 more
core   +1 more source

Genetic diversity of the mumps viruses (Paramyxoviridae: Orthorubulavirus: Mumps orthorubulavirus): an overview

open access: yesВопросы вирусологии, 2022
Mumps is an infectious disease controlled by specific vaccine prophylaxis. To date, its social and epidemiological significance remains high. This is evidenced by the process of developing and implementing into the health care practices of many countries
T. S. Chekhlyaeva   +4 more
doaj   +1 more source

Characteristics of 5-year-olds who catch-up with MMR: findings from the UK Millennium Cohort Study [PDF]

open access: yes, 2013
Objectives To examine predictors of partial and full measles, mumps and rubella (MMR) vaccination catch-up between 3 and 5 years. Design Secondary data analysis of the nationally representative Millennium Cohort Study (MCS).
Bedford, Helen   +3 more
core   +2 more sources

School-based educational and on-site vaccination intervention among adolescents: study protocol of a cluster randomised controlled trial [PDF]

open access: yes, 2019
INTRODUCTION: Childhood vaccination programmes have been established in all Organisation for Economic Co-operation and Development (OECD) countries; however, measles, mumps and rubella (MMR) as well as diphtheria, tetanus, pertussis and polio (Tdap-IPV ...
Bethke, Norma   +2 more
core   +1 more source

THE RESULTS OF STUDY OF THE LEVELS OF SPECIFIC ANTIBODIES TO THE COMBINED INJECTION VACCINES AGAINST INFLUENZA, MEASLES, RUBELLA AND MUMPS AND DT IN CHILDREN WITH CHRONIC PHYSICAL ILLNESS

open access: yesДетские инфекции (Москва), 2015
The levels of antibodies to the separate and combined administration of the vaccine plus Grippol® Plus and vaccines against measles, mumps and/or rubella, diphtheria and tetanus (DT) in children with chronic medical illnesses, including HIV and organic ...
S. M. Haritе   +4 more
doaj   +1 more source

Post-vaccine measles in a child with concomitant influenza, Sicily, Italy, March 2015 [PDF]

open access: yes, 2015
We describe the occurrence of measles in an 18 monthold patient in Sicily, Italy, in March 2015, who received the first dose of a measles-containing vaccine seven days before onset of prodromal symptoms.
Casuccio, N.   +4 more
core   +1 more source

Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman

open access: yesCase Reports in Ophthalmological Medicine, 2016
Purpose. To report a case of unilateral optic neuritis following Measles-Mumps-Rubella (MMR) vaccination. Methods. A 30-year-old female developed unilateral optic neuritis five days after a Measles-Mumps-Rubella (MMR) booster vaccination.
Chiara De Giacinto   +6 more
doaj   +1 more source

Using Real-Time RT-PCR Reagent Kits for Identity Testing of Measles, Mumps and Rubella Vaccines

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
Currently, the identity of measles, mumps and rubella virus vaccines is determined during certification testing by a labour-consuming, lengthy and costly neutralisation test using cell cultures.
A. S. Binyatova   +8 more
doaj   +1 more source

Immunological Protection Against Vaccine-Preventable Infections (Hepatitis B, Measles, Rubella, Mumps, Diphtheria, Tetanus) of Russian and Foreign Students: A Simultaneous Study

open access: yesПедиатрическая фармакология, 2020
The increase in the incidence of vaccine-preventable infections is due to the low level of immunological protection of the population, which against the background of active migration processes can determine high risks of outbreaks of infectious diseases
Diana V. Sutovskaya   +4 more
doaj   +1 more source

Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial [PDF]

open access: yes, 2009
Background When this trial was initiated, the combined measles, mumps and rubella (MMR) vaccine was licensed for subcutaneous administration in all European countries and for intramuscular administration in some countries, whereas varicella vaccine was ...
Yves Gillet   +42 more
core   +1 more source

Home - About - Disclaimer - Privacy